Zobrazeno 1 - 10
of 29
pro vyhledávání: '"P C, Verlander"'
Publikováno v:
Blood. 90(1)
Fanconi anemia (FA) is a genetically and phenotypically heterogeneous disorder defined by cellular hypersensitivity to DNA cross-linking agents; mutations in the gene defective in FA complementation group C, FAC, are responsible for the syndrome in a
Publikováno v:
American journal of medical genetics. 68(1)
Data were analyzed from 419 Fanconi anemia (FA) patients enrolled in the American Registry of the International Fanconi Anemia Registry (IFAR) to determine whether Fanconi anemia (FA) patients without major congenital malformations (CM) have distingu
Publikováno v:
Blood. 86(11)
Fanconi anemia (FA) is a genetically and phenotypically heterogeneous autosomal recessive disorder defined by a cellular hypersensitivity to DNA cross-linking agents. One of the FA genes, FAC, has been cloned and the genomic structure of the coding r
Publikováno v:
The Journal of biological chemistry. 270(17)
The oligomeric structure of Fanconi anemia complementation group C (FACC) was investigated in mammalian cell lysates. Using an affinity-purified polyclonal antibody, FACC was immunoprecipitated from radiolabeled cell lysates and shown to form monomer
Publikováno v:
Blood. 84(5)
We analyzed data from 388 subjects with Fanconi anemia reported to the International Fanconi Anemia Registry (IFAR). Of those, 332 developed hematologic abnormalities at a median age of 7 years (range, birth to 31 years). Actuarial risk of developing
Publikováno v:
American journal of human genetics. 54(4)
Fanconi anemia (FA) is a genetically heterogeneous autosomal recessive disorder characterized by a unique hypersensitivity of cells to DNA cross-linking agents; a gene for complementation group C (FACC) has recently been cloned. We have amplified FAC
Publikováno v:
Pediatrics. 91(6)
The objective of this study was to address the need for early diagnosis of Fanconi anemia (FA), an autosomal recessive chromosomal instability syndrome characterized by a unique cellular hypersensitivity to DNA cross-linking agents, such as diepoxybu
Autor:
Durmaz CD; Department of Medical Genetics, Faculty of Medicine, Hacettepe University, Ankara, Turkey., Gümrük F; Department of Pediatric Hematology, Research Center for Fanconi Anemia and Other Inherited Bone Marrow Failure Syndromes, Hacettepe University, Ankara, Turkey., Celkan T; Department of Pediatric Hematology Oncology, Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey., Unal S; Department of Pediatric Hematology, Research Center for Fanconi Anemia and Other Inherited Bone Marrow Failure Syndromes, Hacettepe University, Ankara, Turkey., Çetinkaya A; Department of Medical Genetics, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Publikováno v:
American journal of medical genetics. Part A [Am J Med Genet A] 2024 Dec 03, pp. e63945. Date of Electronic Publication: 2024 Dec 03.
Autor:
SHAHID, Muhammad1, FIRASAT, Sabika1 sabika.firasat@qau.edu.pk
Publikováno v:
Genetika (0534-0012). 2019, Vol. 51 Issue 3, p1197-1225. 29p.
Autor:
Pilonetto, Daniela V.1 danivp@ufpr.br, Pereira, Noemi F.1, Bonfim, Carmem M. S.2, Ribeiro, Lisandro L.2, Bitencourt, Marco A.2, Kerkhoven, Lianne3, Floor, Karijn3, Ameziane, Najim3, Joenje, Hans3, Gille, Johan J. P.3, Pasquini, Ricardo2
Publikováno v:
Molecular Genetics & Genomic Medicine. Jul2017, Vol. 5 Issue 4, p360-372. 13p.